These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2524855)

  • 1. 5HT1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), inhibits non-opioid analgesia in defeated mice: influence of route of administration.
    Rodgers RJ; Shepherd JK
    Psychopharmacology (Berl); 1989; 97(2):163-5. PubMed ID: 2524855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of route of administration on potency of the selective 5HT-1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, in rats.
    Fuller RW; Snoddy HD
    Res Commun Chem Pathol Pharmacol; 1987 Dec; 58(3):409-12. PubMed ID: 2449711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the putative 5-HT1A receptor agonist 8-OH-2-(di-n-propylamino)tetralin on nociceptive sensitivity in mice.
    Fasmer OB; Berge OG; Post C; Hole K
    Pharmacol Biochem Behav; 1986 Oct; 25(4):883-8. PubMed ID: 2947249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in monkeys.
    Mizuta E; Yamaguchi M; Kuno S
    Eur J Pharmacol; 1990 Mar; 178(1):125-7. PubMed ID: 2139614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J; Sugimoto Y; Horisaka K
    Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin antagonizes the antinociceptive effect of morphine.
    Berge OG; Fasmer OB; Ogren SO; Hole K
    Neurosci Lett; 1985 Feb; 54(1):71-5. PubMed ID: 3156286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (+)-8-OH-DPAT and 5-MeODMT induced analgesia is antagonised by noradrenaline depletion.
    Archer T; Arweström E; Minor BG; Persson ML; Post C; Sundström E; Jonsson G
    Physiol Behav; 1987; 39(1):95-102. PubMed ID: 2951756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypotensive action of 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT) in spontaneously hypertensive rats.
    Martin GE; Lis EV
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):251-61. PubMed ID: 3159366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinemia of the genetically obese (fa/fa) rat is decreased by a low dose of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Chaouloff F; Jeanrenaud B
    Eur J Pharmacol; 1988 Feb; 147(1):111-8. PubMed ID: 2967189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis.
    Fozard JR; Mir AK; Middlemiss DN
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):328-47. PubMed ID: 2437400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone.
    Rodgers RJ; Shepherd JK
    Psychopharmacology (Berl); 1989; 99(3):374-80. PubMed ID: 2574479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT).
    Glennon RA
    Pharmacol Biochem Behav; 1986 Jul; 25(1):135-9. PubMed ID: 2944129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-hydroxytryptamine (HT)1A receptors and the tail-flick response. II. High efficacy 5-HT1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner.
    Millan MJ; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):983-92. PubMed ID: 1672380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicits eating in free-feeding rats by acting on central serotonin neurons.
    Bendotti C; Samanin R
    Eur J Pharmacol; 1986 Feb; 121(1):147-50. PubMed ID: 2937644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentobarbital anaesthesia prevents the adrenaline-releasing effect of the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin.
    Chaouloff F; Baudrie V; Laude D
    Eur J Pharmacol; 1990 May; 180(1):175-8. PubMed ID: 2142092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective agonist of 5-HT1A receptors, on the cough reflex in rats.
    Kamei J; Mori T; Igarashi H; Kasuya Y
    Eur J Pharmacol; 1991 Oct; 203(2):253-8. PubMed ID: 1839282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential antidepressant properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist.
    Cervo L; Samanin R
    Eur J Pharmacol; 1987 Dec; 144(2):223-9. PubMed ID: 2963752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term effects of 8-hydroxy-2-(di-n-propyl-amino)tetralin (8-OH-DPAT) on copulatory and exploratory behaviour in male rats.
    Johansson CE; Meyerson BJ; Höglund AU
    Eur J Pharmacol; 1990 Mar; 178(1):1-9. PubMed ID: 2139613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.